$15.70
0.211.36%
Últ. Act.: Nov 6, 4:00 PM
The average analyst price target for Beta Bionics is $25.06, 59.6% above the current price. Of 15 analysts, 11 rate it Buy and 4 Hold. Targets range from $16 to $40. The latest change came on Oct 28, 2026, when TD Cowen raised its price target on Beta Bionics from $18 to $21 and kept a Hold rating.
Price Target Range — 8 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months